ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag heart attack disease medicine evolution culture

PCSK9 Drug Reduces Heart Disease Risk
Diana Kwon | Mar 21, 2017 | 2 min read
A cholesterol-lowering drug significantly cut the risk of heart attack and stroke in a recent study. But is it worth the steep cost?
The Heart of the Matter
Terry S. Elton, Mahmood Khan, and Dmitry Terentyev | Apr 1, 2011 | 4 min read
By Terry S. Elton, Mahmood Khan, and Dmitry Terentyev The Heart of the Matter Are miRNAs useful for tracking and treating cardiovascular disease? 3D4Medical / Photo Researchers, Inc. Rapid and accurate diagnosis of heart attacks—and the assessment of damage—is critical for improving coronary care. Mature microRNAs (miRNAs) are abundant, easily measured, and relatively stable in blood plasma. If they prove indicative of disease states, miRNAs meas
Ethnicity, At its Heart
Daniel Grushkin | Jan 13, 2010 | 4 min read
Ethnicity, At Its Heart Sonia Anand helped pioneer the largest study of heart risks worldwide—and couldn't believe what she found. By Daniel Grushkin Sonia Anand was perplexed. In 1997, the epidemiologist and MD at McMaster University found that when South Asians move to Canada, their risk of heart attack mysteriously spikes. Though heart disease is the number-one killer worldwide, the rate is 4 percent in rural India. When South Asians live
Evolving heart
Elie Dolgin | Aug 1, 2009 | 3 min read
By Elie Dolgin Evolving heart In 1948, 5,209 residents of a medium-sized New England town signed up for what would become the longest-running, systematic medical study in the world. The Framingham Heart Study, as it was called, was the first to show that smoking, obesity, and high cholesterol all increased people’s chances of developing heart disease. Six decades on, it’s also the first multigenerational human study to reveal that
The Heart of the Matter
Terry S. Elton, Mahmood Khan, and Dmitry Terentyev | Apr 1, 2011 | 4 min read
Are miRNAs useful for tracking and treating cardiovascular disease?
Can Viruses in the Genome Cause Disease?
Katarina Zimmer | Jan 1, 2019 | 10+ min read
Clinical trials that target human endogenous retroviruses to treat multiple sclerosis, ALS, and other ailments are underway, but many questions remain about how these sequences may disrupt our biology.
Omega-3s: Fishing for a Mechanism
Ethan J. Anderson and David A. Taylor | Nov 1, 2012 | 10+ min read
Despite abundant evidence supporting their ability to help prevent and treat cardiovascular disease, the therapeutic effectiveness of fish oil–derived fatty acids remains controversial.
Notebook
The Scientist Staff | Feb 14, 1999 | 5 min read
Editor's Note: The news items on this page all originated from the American Association for the Advancement of Science annual meeting in Anaheim, Calif., Jan. 21-26. PLAQUE ATTACK A host of studies have bitten off the task of linking periodontitis with coronary heart disease. But without more evidence, scientists may find any cause-and-effect relationship between tooth disease and heart attacks hard to swallow, admitted James D. Beck, professor of dental ecology, at the University of North Caro
Alternative Medicines
The Scientist | Jul 1, 2012 | 10+ min read
As nonconventional medical treatments become increasingly mainstream, we take a look at the science behind some of the most popular.
Book Excerpt from Looking for a Few Good Males
Erika Lorraine Milam | Dec 31, 2010 | 10+ min read
In Chapter 2, "Progressive Desire," author Erika Lorraine Milam explores sexual selection’s incursion into evolutionary theory.

Run a Search

ADVERTISEMENT